{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:35:40Z","timestamp":1792888540088,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)","id":[{"id":"https:\/\/ror.org\/00f2yqf98","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This study sought to evaluate the characteristics of clinical-pharmacological (CP) medication reviews conducted by the Institute for Clinical Pharmacology of Hannover Medical School for older, multimorbid, polymedicated insurants of the German statutory health insurance fund\n                    <jats:italic>Kaufm\u00e4nnische Krankenkasse<\/jats:italic>\n                    (KKH). Special emphasis was put on potential sex-specific differences between female and male insurants, prescriptions of potentially inappropriate medications for older individuals (PIMs), and potentially inappropriate duplicate prescriptions (PIDPs). Medication reviews conducted for KKH insurants between 2019 and 2023 (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009334) were analyzed retrospectively. Clinical trial number is not applicable. The median age of KKH insurants (58.1% female) was 74\u00a0years (first quartile (Q1): 68; third quartile (Q3): 80). Insurants displayed a median of 7 diseases (Q1: 5; Q3: 9) and took a median of 13 drugs (Q1: 11; Q3: 16). A median of 4 CP recommendations was issued per medication review (Q1: 3; Q3: 5). The number of CP recommendations was significantly higher for female compared to male insurants (median of 4 (Q1: 3; Q3: 6) vs. median of 3 recommendations (Q1: 2; Q3: 4);\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), while the number of drugs was identical and the number of diagnoses was higher for female insurants. The most frequently prescribed PIMs were tricyclic antidepressants, benzodiazepines, and Z-drugs. At least one PIDP was detected in 16.5% of medication reviews. The sex-specific difference in the number of CP recommendations between female and male insurants may point to an unmet pharmacotherapeutic need in older women. PIM prescriptions and PIDPs were relevant topics of CP recommendations, suggesting possibilities for pharmacotherapeutic optimization in older, multimorbid, polymedicated patients.\n                  <\/jats:p>","DOI":"10.1007\/s00210-026-05741-8","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:46:19Z","timestamp":1784691979000},"page":"21449-21463","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical-pharmacological medication reviews for insurants of a German statutory health insurance fund (Kaufm\u00e4nnische Krankenkasse (KKH)): a 5-year retrospective analysis (2019\u20132023)"],"prefix":"10.1007","volume":"399","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5382-3014","authenticated-orcid":false,"given":"Johannes","family":"Heck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6526-0917","authenticated-orcid":false,"given":"Dirk O.","family":"Stichtenoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Herbarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3541-8987","authenticated-orcid":false,"given":"Christoph","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxandra","family":"Sabau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1031-1913","authenticated-orcid":false,"given":"Thorben","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0905-274X","authenticated-orcid":false,"given":"Sebastian","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5899-0113","authenticated-orcid":false,"given":"Benjamin","family":"Krichevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3262-8137","authenticated-orcid":false,"given":"Martin","family":"Schulze Westhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3054-9905","authenticated-orcid":false,"given":"Martin","family":"Klietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0638-8571","authenticated-orcid":false,"given":"Stephan","family":"Greten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3168-7074","authenticated-orcid":false,"given":"Patrick-Pascal","family":"Strunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3012-4245","authenticated-orcid":false,"given":"Carsten","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"5741_CR1","unstructured":"130 Jahre KKH: Ein R\u00fcckblick (n.d.) Available at: https:\/\/www.kkh.de\/unternehmen\/130-jahre-kkh. Accessed 12 Dec 2024"},{"key":"5741_CR2","doi-asserted-by":"publisher","DOI":"10.2196\/74304","volume":"28","author":"AS Abuzour","year":"2026","unstructured":"Abuzour AS, Wilson SA, Woodall AA, Mair FS, Aslam A, Clegg A et al (2026) Developing an AI-assisted tool that identifies patients with multimorbidity and complex polypharmacy to improve the process of medication reviews: qualitative interview and focus group study. J Med Internet Res 28:e74304","journal-title":"J Med Internet Res"},{"issue":"7","key":"5741_CR3","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","volume":"71","author":"American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2023","unstructured":"American Geriatrics Society Beers Criteria\u00ae Update Expert Panel (2023) American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc 71(7):2052\u20132081","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"5741_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ph16111542","volume":"16","author":"CM Bellanca","year":"2023","unstructured":"Bellanca CM, Augello E, Cantone AF, Di Mauro R, Attaguile GA, Di Giovanni V et al (2023) Insight into risk factors, pharmacogenetics\/genomics, and management of adverse drug reactions in elderly: a narrative review. Pharmaceuticals (Basel) 16(11):1542","journal-title":"Pharmaceuticals (Basel)"},{"issue":"23","key":"5741_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare12232337","volume":"12","author":"D Berardinelli","year":"2024","unstructured":"Berardinelli D, Conti A, Hasnaoui A, Casabona E, Martin B, Campagna S et al (2024) Nurse-led interventions for improving medication adherence in chronic diseases: a systematic review. Healthcare (Basel) 12(23):2337","journal-title":"Healthcare (Basel)"},{"issue":"1","key":"5741_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12916-018-1007-9","volume":"16","author":"J Beuscart","year":"2018","unstructured":"Beuscart J, Knol W, Cullinan S, Schneider C, Dalleur O, Boland B et al (2018) International core outcome set for clinical trials of medication review in multi-morbid older patients with polypharmacy. BMC Med 16(1):21","journal-title":"BMC Med"},{"key":"5741_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2025.112019","author":"LM Bjerre","year":"2026","unstructured":"Bjerre LM, Halil R, Catley C, Smith G, Ramsay T, Cahir C et al (2026) Identifying potentially inappropriate prescribing in entire populations: coding the STOPP-START and Beers criteria for use with large, routinely collected population health datasets. J Clin Epidemiol. https:\/\/doi.org\/10.1016\/j.jclinepi.2025.112019","journal-title":"J Clin Epidemiol"},{"key":"5741_CR8","unstructured":"Boldt K (2015) Entwicklung einer Vorgehensweise zur automatisierten Erkennung eines Bedarfs an klinisch-pharmazeutischer Betreuung aus GKV-Routinedaten mittels Data-Mining. Available at: https:\/\/nbn-resolving.de\/urn:nbn:de:gbv:46-00104424-13. Accessed 12 Dec 2024"},{"key":"5741_CR9","first-page":"693","volume":"16","author":"A Bollinger","year":"2023","unstructured":"Bollinger A, St\u00e4uble CK, Jeiziner C, Wiss FM, Hersberger KE, Lampert ML et al (2023) Genotyping of patients with adverse drug reaction or therapy failure: database analysis of a pharmacogenetics case series study. Pharmgenomics Pers Med 16:693\u2013706","journal-title":"Pharmgenomics Pers Med"},{"issue":"8","key":"5741_CR10","volume":"17","author":"K Bringhurst","year":"2025","unstructured":"Bringhurst K, Jones T, Runko G, Jabbari M, Zipparro N, Nghi Vo G et al (2025) Artificial intelligence in the management of polypharmacy among older adults: a scoping review. Cureus 17(8):e90867","journal-title":"Cureus"},{"issue":"728","key":"5741_CR11","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.3399\/BJGP.2022.0181","volume":"73","author":"AS Doherty","year":"2023","unstructured":"Doherty AS, Boland F, Moriarty F, Fahey T, Wallace E (2023) Adverse drug reactions and associated patient characteristics in older community-dwelling adults: a 6-year prospective cohort study. Br J Gen Pract 73(728):e211\u2013e219","journal-title":"Br J Gen Pract"},{"issue":"44","key":"5741_CR12","first-page":"745","volume":"119","author":"T Dreischulte","year":"2022","unstructured":"Dreischulte T, Shahid F, Muth C, Schmiedl S, Haefeli WE (2022) Prescribing cascades: how to detect them, prevent them, and use them appropriately. Dtsch Arztebl Int 119(44):745\u2013752","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"5741_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/jebm.70015","volume":"18","author":"L Engels","year":"2025","unstructured":"Engels L, van den Akker M, Denig P, Stoffers H, Gerger H, Bohnen J et al (2025) Medication management in patients with polypharmacy in primary care: a scoping review of clinical practice guidelines. J Evid Based Med 18(1):e70015","journal-title":"J Evid Based Med"},{"issue":"2","key":"5741_CR14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S1086-5802(16)31229-3","volume":"41","author":"FR Ernst","year":"2001","unstructured":"Ernst FR, Grizzle AJ (2001) Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash) 41(2):192\u2013199","journal-title":"J Am Pharm Assoc (Wash)"},{"key":"5741_CR15","doi-asserted-by":"crossref","unstructured":"Extavour RM, Perri M 3 (2018) Patient, physician, and health-system factors influencing the quality of antidepressant and sedative prescribing for older, community-dwelling adults. Health Serv Res 53(1):405\u2013429","DOI":"10.1111\/1475-6773.12641"},{"key":"5741_CR16","doi-asserted-by":"publisher","DOI":"10.1017\/pcm.2023.10","volume":"1","author":"K Fujita","year":"2023","unstructured":"Fujita K, Masnoon N, Mach J, O\u2019Donnell LK, Hilmer SN (2023) Polypharmacy and precision medicine. Camb Prism Precis Med 1:e22","journal-title":"Camb Prism Precis Med"},{"issue":"5","key":"5741_CR17","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s11096-018-0696-7","volume":"40","author":"N Griese-Mammen","year":"2018","unstructured":"Griese-Mammen N, Hersberger KE, Messerli M, Leikola S, Horvat N, van Mil JWF et al (2018) PCNE definition of medication review: reaching agreement. Int J Clin Pharm 40(5):1199\u20131208","journal-title":"Int J Clin Pharm"},{"issue":"12","key":"5741_CR18","doi-asserted-by":"publisher","first-page":"572","DOI":"10.5414\/CP203372","volume":"56","author":"WE Haefeli","year":"2018","unstructured":"Haefeli WE, Meid AD (2018) Pill-count and the arithmetic of risk: evidence that polypharmacy is a health status marker rather than a predictive surrogate for the risk of adverse drug events. Int J Clin Pharmacol Ther 56(12):572\u2013576","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"12","key":"5741_CR19","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2217\/pgs-2021-0032","volume":"22","author":"J Hayward","year":"2021","unstructured":"Hayward J, McDermott J, Qureshi N, Newman W (2021) Pharmacogenomic testing to support prescribing in primary care: a structured review of implementation models. Pharmacogenomics 22(12):761\u2013776","journal-title":"Pharmacogenomics"},{"issue":"2","key":"5741_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00228-022-03436-6","volume":"79","author":"J Heck","year":"2023","unstructured":"Heck J, Krichevsky B, Groh A, Schulze Westhoff M, Laser H, Gerbel S et al (2023) Duplicate prescriptions in the emergency department: a retrospective cohort study. Eur J Clin Pharmacol 79(2):207\u2013217","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"5741_CR21","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s00228-021-03143-8","volume":"77","author":"J Heck","year":"2021","unstructured":"Heck J, Krichevsky B, Stichtenoth DO, Zu Siederdissen CH, Krause O (2021) Duplicate prescriptions\u2014proposal of a clinically oriented categorisation. Eur J Clin Pharmacol 77(10):1589\u20131591","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"5741_CR22","doi-asserted-by":"publisher","first-page":"19409","DOI":"10.1038\/s41598-022-24005-y","volume":"12","author":"J Heck","year":"2022","unstructured":"Heck J, Stichtenoth DO, Sabau R, Schr\u00f6der C, Engeli S, Pape T et al (2022) Clinical-pharmacological drug information center of Hannover Medical School: experiences and analysis from a tertiary care university hospital. Sci Rep 12(1):19409","journal-title":"Sci Rep"},{"issue":"2","key":"5741_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.70247","volume":"14","author":"J Heck","year":"2026","unstructured":"Heck J, Stichtenoth DO, Schr\u00f6der C, Sabau R, Heim AK, Koop F et al (2026) Clinical-pharmacological drug information center of Hannover Medical School: update from a tertiary care university hospital (2022\u20132024). Pharmacol Res Perspect 14(2):e70247","journal-title":"Pharmacol Res Perspect"},{"issue":"10","key":"5741_CR24","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1111\/bcp.15815","volume":"89","author":"BJ Hjem\u00e5s","year":"2023","unstructured":"Hjem\u00e5s BJ, B\u00f8vre K, Bjerknes K, Mathiesen L, Mellingsaeter MCR, Molden E (2023) Implementation of pharmacogenetic testing in medication reviews in a hospital setting. Br J Clin Pharmacol 89(10):3116\u20133125","journal-title":"Br J Clin Pharmacol"},{"issue":"31\u201332","key":"5741_CR25","first-page":"543","volume":"107","author":"S Holt","year":"2010","unstructured":"Holt S, Schmiedl S, Th\u00fcrmann PA (2010) Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int 107(31\u201332):543\u2013551","journal-title":"Dtsch Arztebl Int"},{"issue":"6","key":"5741_CR26","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1016\/j.sapharm.2021.07.025","volume":"18","author":"H Kari","year":"2022","unstructured":"Kari H, \u00c4ij\u00f6-Jensen N, Kortej\u00e4rvi H, Ronkainen J, Yliperttula M, Laaksonen R et al (2022) Effectiveness and cost-effectiveness of a people-centred care model for community-living older people versus usual care \u2500 a randomised controlled trial. Res Social Adm Pharm 18(6):3004\u20133012","journal-title":"Res Social Adm Pharm"},{"issue":"1","key":"5741_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12877-018-0929-6","volume":"18","author":"EK Kiesel","year":"2018","unstructured":"Kiesel EK, Hopf YM, Drey M (2018) An anticholinergic burden score for German prescribers: score development. BMC Geriatr 18(1):239","journal-title":"BMC Geriatr"},{"key":"5741_CR28","unstructured":"KKH Kaufm\u00e4nnische Krankenkasse (n.d.) Unternehmensportr\u00e4t. Available at: https:\/\/www.kkh.de\/unternehmen\/kurzportraet. Accessed 12 Dec 2024"},{"issue":"1","key":"5741_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11096-017-0559-7","volume":"40","author":"T Koyama","year":"2018","unstructured":"Koyama T, Onoue H, Ohshima A, Tanaka Y, Tatebe Y, Zamami Y et al (2018) Trends in the medication reviews of community pharmacies in Japan: a nationwide retrospective study. Int J Clin Pharm 40(1):101\u2013108","journal-title":"Int J Clin Pharm"},{"key":"5741_CR30","unstructured":"Krankenkassen Deutschland (n.d.) Die gr\u00f6\u00dften Krankenkassen: Zahl der Versicherten. Available at: https:\/\/www.krankenkassen.de\/krankenkassen-vergleich\/statistik\/versicherte\/aktuell\/. Last updated: April 01, 2026. Accessed 29 June 2026"},{"issue":"3","key":"5741_CR31","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/bcp.70321","volume":"92","author":"B Krichevsky","year":"2026","unstructured":"Krichevsky B, Engeli S, Bode-B\u00f6ger SM, Koop F, Schulze Westhoff M, Schr\u00f6der S et al (2026) Human vs. artificial intelligence: physicians outperform ChatGPT in real-world pharmacotherapy counselling. Br J Clin Pharmacol 92(3):891\u2013902","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"5741_CR32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s40267-018-0507-1","volume":"34","author":"F Laidig","year":"2018","unstructured":"Laidig F, May M, Brinkmann J, Schneider N, Stichtenoth DO (2018) Evaluation of potential prescribing errors in patients with polypharmacy: a method to improve medication safety in ambulatory care. Drugs Ther Perspect 34(7):322\u2013334","journal-title":"Drugs Ther Perspect"},{"key":"5741_CR33","doi-asserted-by":"crossref","unstructured":"Mann N, Mathes T, S\u00f6nnichsen A, Pieper D, Klager E, Moussa M et al (2023) Potentially inadequate medications in the elderly: PRISCUS 2.0\u2014first update of the PRISCUS list. Dtsch Arztebl Int 120(Forthcoming):3\u201310","DOI":"10.3238\/arztebl.m2022.0377"},{"key":"5741_CR34","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.2147\/JMDH.S276061","volume":"13","author":"A Mardani","year":"2020","unstructured":"Mardani A, Griffiths P, Vaismoradi M (2020) The role of the nurse in the management of medicines during transitional care: a systematic review. J Multidiscip Healthc 13:1347\u20131361","journal-title":"J Multidiscip Healthc"},{"issue":"5","key":"5741_CR35","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.12931","volume":"8","author":"EG McDonald","year":"2025","unstructured":"McDonald EG, Estey JL, Davenport C, Bortolussi-Courval \u00c9, Gaudet J, Wilson Registe PP et al (2025) Electronic decision support for deprescribing in older adults living in long-term care: a stepped-wedge cluster randomized trial. JAMA Netw Open 8(5):e2512931","journal-title":"JAMA Netw Open"},{"issue":"6","key":"5741_CR36","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1007\/s11096-022-01434-3","volume":"44","author":"R Moecker","year":"2022","unstructured":"Moecker R, Fuchs A, ARMIN Study Group, Haefeli WE, Weissenborn M, Seidling HM (2022) Attitudes of non-participating general practitioners and community pharmacists towards interprofessional medication management in primary care: an interview study. Int J Clin Pharm 44(6):1380\u20131393","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"5741_CR37","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s41999-023-00777-y","volume":"14","author":"D O\u2019Mahony","year":"2023","unstructured":"O\u2019Mahony D, Cherubini A, Guiteras AR, Denkinger M, Beuscart J, Onder G et al (2023) STOPP\/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med 14(4):625\u2013632","journal-title":"Eur Geriatr Med"},{"issue":"2","key":"5741_CR38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41397-021-00260-6","volume":"22","author":"J O\u2019Shea","year":"2022","unstructured":"O\u2019Shea J, Ledwidge M, Gallagher J, Keenan C, Ryan C (2022) Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review. Pharmacogenomics J 22(2):89\u201399","journal-title":"Pharmacogenomics J"},{"issue":"6","key":"5741_CR39","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00228-017-2225-3","volume":"73","author":"TJ Oscanoa","year":"2017","unstructured":"Oscanoa TJ, Lizaraso F, Carvajal A (2017) Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis. Eur J Clin Pharmacol 73(6):759\u2013770","journal-title":"Eur J Clin Pharmacol"},{"key":"5741_CR40","unstructured":"Pharmaceutical Care Network Europe (PCNE) (2013a) Overview: what problems can be detected by the different PCNE types of medication review. Available at: https:\/\/www.pcne.org\/working-groups\/1\/medication-review\/18. Accessed 04 Dec 2024"},{"key":"5741_CR41","unstructured":"Pharmaceutical Care Network Europe (PCNE) (2013b) Overview: what activities are part of the different PCNE types of medication review. Available at: https:\/\/www.pcne.org\/working-groups\/1\/medication-review\/18. Accessed 04 Dec 2024"},{"issue":"8","key":"5741_CR42","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1001\/jamainternmed.2018.2372","volume":"178","author":"SD Persell","year":"2018","unstructured":"Persell SD, Karmali KN, Lazar D, Friesema EM, Lee JY, Rademaker A et al (2018) Effect of electronic health record-based medication support and nurse-led medication therapy management on hypertension and medication self-management: a randomized clinical trial. JAMA Intern Med 178(8):1069\u20131077","journal-title":"JAMA Intern Med"},{"issue":"6","key":"5741_CR43","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/bcp.12732","volume":"80","author":"E Reeve","year":"2015","unstructured":"Reeve E, Gnjidic D, Long J, Hilmer S (2015) A systematic review of the emerging definition of \u2018deprescribing\u2019 with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol 80(6):1254\u20131268","journal-title":"Br J Clin Pharmacol"},{"key":"5741_CR44","unstructured":"Roche Products Limited (2020) Summary of product characteristics madopar 200mg\/50mg Hard Capsules. Available at: https:\/\/www.medicines.org.uk\/emc\/product\/6926\/smpc#about-medicine. Accessed 03 Dec 2024"},{"issue":"9","key":"5741_CR45","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2165\/00019053-200321090-00002","volume":"21","author":"R Rodr\u00edguez-Mongui\u00f3","year":"2003","unstructured":"Rodr\u00edguez-Mongui\u00f3 R, Otero MJ, Rovira J (2003) Assessing the economic impact of adverse drug effects. Pharmacoeconomics 21(9):623\u2013650","journal-title":"Pharmacoeconomics"},{"issue":"44","key":"5741_CR46","first-page":"776","volume":"107","author":"A Schneider","year":"2010","unstructured":"Schneider A, Hommel G, Blettner M (2010) Linear regression analysis. Dtsch Arztebl Int 107(44):776\u2013782","journal-title":"Linear regression analysis. Dtsch Arztebl Int"},{"issue":"2","key":"5741_CR47","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/psyg.12940","volume":"23","author":"M Schulze Westhoff","year":"2023","unstructured":"Schulze Westhoff M, Schr\u00f6der S, Groh A, Frieling H, Bleich S, Koop F et al (2023) Sedatives and analgesics are major contributors to potentially inappropriate duplicate prescriptions in geriatric psychiatry. Psychogeriatrics 23(2):354\u2013363","journal-title":"Psychogeriatrics"},{"issue":"5","key":"5741_CR48","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","volume":"175","author":"IA Scott","year":"2015","unstructured":"Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D et al (2015) Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med 175(5):827\u2013834","journal-title":"JAMA Intern Med"},{"issue":"2","key":"5741_CR49","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.sapharm.2025.11.005","volume":"22","author":"S Scott","year":"2026","unstructured":"Scott S, Martin-Kerry J, Pritchard M, Atkins B, Clark AB, Grant K et al (2026) The feasibility of implementing a hospital deprescribing behaviour change intervention and undertaking trial processes: a mixed methods evaluation. Res Social Adm Pharm 22(2):333\u2013339","journal-title":"Res Social Adm Pharm"},{"key":"5741_CR50","volume":"15","author":"K Sridharan","year":"2024","unstructured":"Sridharan K, Sivaramakrishnan G (2024) Unlocking the potential of advanced large language models in medication review and reconciliation: a proof-of-concept investigation. Explor Res Clin Soc Pharm 15:100492","journal-title":"Explor Res Clin Soc Pharm"},{"key":"5741_CR51","unstructured":"Statistisches Bundesamt (Federal Statistical Office) (2024) Population: deaths, life expectancy. Available at: https:\/\/www.destatis.de\/EN\/Themes\/Society-Environment\/Population\/Deaths-Life-Expectancy\/_node.html#268862. Accessed 03 Dec 2024"},{"issue":"6","key":"5741_CR52","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1007\/s11096-021-01306-2","volume":"43","author":"M Stuhec","year":"2021","unstructured":"Stuhec M (2021) Clinical pharmacist consultant in primary care settings in Slovenia focused on elderly patients on polypharmacy: successful national program from development to reimbursement. Int J Clin Pharm 43(6):1722\u20131727","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"5741_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53057-w","volume":"9","author":"M Stuhec","year":"2019","unstructured":"Stuhec M, Bratovi\u0107 N, Mrhar A (2019) Impact of clinical pharmacist\u2019s interventions on pharmacotherapy management in elderly patients on polypharmacy with mental health problems including quality of life: a prospective non-randomized study. Sci Rep 9(1):16856","journal-title":"Sci Rep"},{"issue":"15\u201316","key":"5741_CR54","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1007\/s00508-020-01801-y","volume":"133","author":"M Stuhec","year":"2021","unstructured":"Stuhec M, Flegar I, Zelko E, Kova\u010di\u010d A, Zabavnik V (2021) Clinical pharmacist interventions in cardiovascular disease pharmacotherapy in elderly patients on excessive polypharmacy: a retrospective pre-post observational multicentric study. Wien Klin Wochenschr 133(15\u201316):770\u2013779","journal-title":"Wien Klin Wochenschr"},{"issue":"1","key":"5741_CR55","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12913-019-3942-3","volume":"19","author":"M Stuhec","year":"2019","unstructured":"Stuhec M, Gorenc K, Zelko E (2019) Evaluation of a collaborative care approach between general practitioners and clinical pharmacists in primary care community settings in elderly patients on polypharmacy in Slovenia: a cohort retrospective study reveals positive evidence for implementation. BMC Health Serv Res 19(1):118","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"5741_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.aggp.2025.100185","volume":"2","author":"H Sutanto","year":"2025","unstructured":"Sutanto H (2025) Tackling polypharmacy in geriatric patients: is increasing physicians\u2019 awareness adequate? Arch Gerontol Geriatr plus 2(3):100185","journal-title":"Arch Gerontol Geriatr plus"},{"key":"5741_CR57","unstructured":"University of Toronto, University of British Columbia, Bruy\u00e8re Research Institute Ottawa (2026) Deprescribing.org\u2014reducing medications safely to meet life\u2019s changes. Available at: https:\/\/deprescribing.org\/. Accessed 13 July 2026"},{"issue":"8","key":"5741_CR58","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.sapharm.2024.03.012","volume":"20","author":"CJ Vogt","year":"2024","unstructured":"Vogt CJ, Moecker R, Jacke CO, Haefeli WE, Seidling HM (2024) Exploring the heterogeneity in community pharmacist-led medication review studies - a systematic review. Res Social Adm Pharm 20(8):679\u2013688","journal-title":"Res Social Adm Pharm"},{"issue":"4","key":"5741_CR59","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40266-023-01015-7","volume":"40","author":"J Wang","year":"2023","unstructured":"Wang J, James S, Hilmer SN, Aitken SJ, Soo G, Naganathan V et al (2023) Optimising medications in older vascular surgery patients through geriatric co-management. Drugs Aging 40(4):335\u2013342","journal-title":"Drugs Aging"},{"issue":"4","key":"5741_CR60","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/jppr2003334323","volume":"33","author":"MC Woodward","year":"2003","unstructured":"Woodward MC (2003) Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res 33(4):323\u2013328","journal-title":"J Pharm Pract Res"},{"key":"5741_CR61","unstructured":"World Health Organization (2017) Medication without harm\u2014WHO global patient safety challenge. Available at: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/255263\/WHO-HIS-SDS-2017.6-eng.pdf;jsessionid=58DB8448FDAE8CA2AEE700D9F946859A?sequence=1. Accessed 04 Dec 2024"},{"key":"5741_CR62","unstructured":"World Health Organization (2024) Obesity and overweight. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight. Accessed 12 Dec 2024"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05741-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05741-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05741-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:02:04Z","timestamp":1792886524000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05741-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":62,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["5741"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05741-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"5 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}